So, I’m in or about to enter into negotiations with a potential suitor(s). I’ve got a truly disruptive molecule that some might tout as the next aspirin in terms of reach. I’m a micro biotech with about 25 key people, nearly all are executive level with medical type backgrounds. I’m not vertically integrated as i’m in development mode with a number of trials going in. i’m patent protected for at least 12 years and potential indications for my lead moecule are boundless. In fact, i’ve got a portfolio of products that could disrupt some key players in my industry. For a micro bio i’ve got a clean balance sheet, cash for two years and lifeline to sustain existing operations for a few more if necessary.
I’ve looked at my core competency and leverage as i’m about to enter negotiations:
- leadership team -check
- disruptive products-check
- trials funded-check
- peer acceptance -check
- patent protected -check
- market reach and depth -check
- fortress balance sheet - check
- cash infusion lifeline to sustain operations- check
- low outstanding shares -check
- fda or regulatory approval -
- vertically integrated or ability to get there -
seems i have two items to close. how to close those gaps to magnify my negotiating leverage?
fda or regulatory approval - trial readouts due out shortly (they dictate if approval forthcoming), some models say i’m nearly at 80% probability for approval
vertically integrated or ability to get there - guess i need the potential to raise big time cash to fund my growth. my key advisors, industry finance guys and lawyers all agree I need to seek a shelf offering with SEC. No need to execute but just in case those trial results come back favorable.
Wow looks like i’ve got All boxes checked. I’m now fully prepared to commence serious negotiations. i’ve got leverage in all competencies. Hope the negotiations yield the right offer. If not, i just walk away and on to plan B.
Anavex leadership is brilliant. Absolutely brilliant.
Market Data 
Markets 
